Spruce Biosciences to wind down investment for genetic disorder drug-March 2024-www.financetom.com

Spruce Biosciences to wind down investment for genetic disorder drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Spruce Biosciences to wind down investment for genetic disorder drug

Dec 10, 2024 1:23 PM

Dec 10 (Reuters) - Spruce Biosciences ( SPRB ) said on

Tuesday it will wind down investments for its genetic disorder

drug after it failed to meet the main goal in a mid-stage study.

Previous page： BRIEF-IBM To Acquire Accelalpha, Leading Oracle Consultancy Next page： BRIEF-Labcorp To Acquire Select Outreach Services From Ballad Health

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-IBM To Acquire Accelalpha, Leading Oracle Consultancy

Sep 11, 2024

International Business Machines Corp ( IBM ): * IBM TO ACQUIRE ACCELALPHA, LEADING ORACLE CONSULTANCY * IBM ( IBM ) - FINANCIAL DETAILS OF TRANSACTION WERE NOT DISCLOSED. Source text for Eikon: Further company coverage: ...

BRIEF-Labcorp To Acquire Select Outreach Services From Ballad Health

Sep 11, 2024

Labcorp Holdings Inc ( LH ): * LABCORP TO ACQUIRE SELECT OUTREACH SERVICES FROM BALLAD HEALTH Source text for Eikon: Further company coverage: ...

BRIEF-Liberty Media And Sirius Xm Announce Completion Of Split-Off And Merger

Sep 11, 2024

Liberty Media Corp ( LLYVB ): * LIBERTY MEDIA AND SIRIUS XM ANNOUNCE COMPLETION OF SPLIT-OFF AND MERGER Source text for Eikon: Further company coverage: ...

BRIEF-HGGC Signed Agreement To Sell AMI To Investment Firm THL Partners

Sep 11, 2024

Sept 9 (Reuters) - HGGC: * HGGC - SIGNED A DEFINITIVE AGREEMENT TO SELL AMI TO INVESTMENT FIRM THL PARTNERS * HGGC - TERMS OF PRIVATE TRANSACTION WERE NOT DISCLOSED Source text for Eikon: ...